generationbio.com - GBIO Quarterly EPS earnings growth

Corporate emblem and logo of generationbio.com (GBIO)

Generation Bio Co. (GBIO) maintains an impeccable reputation among geneticists for developing non-viral medicines. The company is integrating AI algorithms into bioreactor modules to automate drug synthesis. Its universal gene therapy platform ensures high scalability and licensing revenues. The trend of quarterly earnings per share growth illustrates the pace of revenue recovery, while the 64.00 metric reflects current dynamics.

Generation Bio (GBIO) Earnings per share growth in annualized terms for the last twelve months: for the period 07/04/2022 - 02/21/2026

Generation Bio Co. (GBIO) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Stock Quotes generationbio.com|GBIO - Analyst Forecast Prices
- issuer market value details:
Market Capitalization Generation Bio Corp|GBIO - Company Buyout Price
- balance sheet net asset value indicators:
Net Assets per Single Share Generation Bio|GBIO - Total Stockholders' Equity|Market Value to Book Value Ratio generationbio.com|GBIO - Total Business Assets
- debt level and financial liquidity data:
Total Debt to Equity Ratio Generation Bio Co.|GBIO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital generationbio.com|GBIO - Company Debts|Debts to Book Capitalization Generation Bio Corp|GBIO - Long-Term Debt Volume|Company Short-Term Debt Generation Bio|Quick Liquidity Indicator generationbio.com
- earnings and market multiples details:
GBIO - Final Profit|Projected Future Earnings Generation Bio Co.|GBIO - Price to Earnings Ratio|Future Price to Earnings generationbio.com|GBIO - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Generation Bio Corp|GBIO - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Generation Bio|GBIO - Net earnings per share for the trailing year|Quarterly EPS earnings growth generationbio.com|GBIO - Earnings per share growth in current year|Earnings growth forecast for next year Generation Bio Co.
Fundamental valuation:Generation Bio Co - GBIO
Finished products of Generation Bio Co.

When constructing a long-term portfolio, fundamental screening requires an analysis of earnings per share growth rates to confirm operational efficiency. This calculation captures the rolling change in net income, which is critical for Generation Bio Co. (GBIO) amid fierce competition with genetic engineering behemoths; therefore, the quarterly EPS dynamics on GURU.Markets serve as an indicator of the company's business model viability.

Competitors of Generation Bio Co. (GBIO)

TEM (Tempus AI Inc) - Year-over-year net earnings per share growth for the last 12 months|QGEN: Year-over-year earnings per share growth rate for the last twelve months|IONS (Ionis Pharma) - Quarterly EPS earnings growth|Repligen Inc. (RGEN) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Avidity Biosciences (RNA)|CRSP - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months GeneDx WGS|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SRPT (Sarepta Corp)|TWST: Quarterly EPS earnings growth|TXG (10xgenomics.com) - Year-over-year earnings per share growth for the last twelve months|NTLA (Intellia Therapeutics, Inc.) - Quarterly EPS earnings growth|Stoke Therapeutics Inc (STOK) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months BioLife Corp (BLFS)|WVE - Earnings per share growth in annualized terms for the last twelve months|Maze Therapeutics Inc - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SION|Prime Medicine - Quarterly EPS earnings growth|Taysha Gene Therapies Inc (TSHA) - Year-over-year net earnings per share growth for the last 12 months|uniQure Corp (QURE) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months MeiraGTx Corp (MGTX)|Year-over-year net earnings per share growth for the last 12 months RGNX|solidbio.com (SLDB) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth OCGN|Pacific Biosciences of California, Inc. (PACB) - Net earnings per share growth for the trailing year|Quarterly EPS earnings growth BNTC (Benitec)|Design Corp - Year-over-year earnings per share growth for the last twelve months|Rocket Pharmaceuticals - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months 4dmoleculartherapeutics.com FDMT|lexeotx.com (LXEO) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Korro Bio (KRRO)|EDIT (Editas) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months SLN (Silence Therapeutics Corp)|Year-over-year earnings per share growth for the last twelve months ProQR Therapeutics N.V. (PRQR)|codexis.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth SGMO (Sangamo Therapeutics, Inc.)|Quarterly EPS earnings growth Nautilus Biotechnology, Inc. NAUT|Metagenomi, Inc - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year precisionbiosciences.com (DTIL)|BOLD: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Exicure (XCUR)|Year-over-year earnings per share growth for the last twelve months Imunon Inc|Year-over-year earnings per share growth for the last 12 months PHIO (RXi Pharmaceuticals)|Quarterly EPS earnings growth MBIO|RNAZ - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Bionano Genomics BNGO|Year-over-year earnings per one share growth for the last 12 months APDN|bluebird bio - Quarterly EPS earnings growth|IPA - Quarterly EPS earnings growth|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|OMIC: Year-over-year earnings per share growth rate for the last twelve months|RGLS (Regulus Therapeutics) - Quarterly EPS earnings growth|syros.com (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Telesis Bio (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Unity Bio UBX